retatrutide trials ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Lilly's triple agonist, retatrutide, delivered

TLR4:Toll-like receptor 4

Research suggests weight regain is common after complete discontinuation without adequate lifestyle modification, which is why a structured taper and maintenance plan matters

Parkinson's disease Huntington's disease ALS amyotrophic lateral sclerosis the mimics may be used for the treatment of "depression, by which we mean major depressive disorder (MDD) (also known as recurrent depressive disorder, clinical depression, major depression, unipolar depression, or unipolar disorder) and also depression that is characteristic of bipolar disorder, etc

Navigating Cold & Flu Season on GLP-1 Sick with a cold or flu while on GLP-1

Treatment duration is generally limited to 812 weeks before cycling off to evaluate response [9]